#ESMOMembers 📢 Voting for the ESMO President 2029-2030 is open. #ESMOElections An invitation from @FAndreMD to learn more about the candidates and their vision for the Society. Cast your vote 🔗ow.ly/M2Ja50Z4aVW

Back in Berlin this year! Growing year after year. Led by amazing @stolaney1 @myESMO #ESMOBreast26

Weekly #BreastCancer Newsletter- My take of last week’s publications from select high-impact journals (April 13 - April 19, 2026). @OncoDailyBreast @oncodaily #BCSM #BreastCancerResearch #BreastCancer

A recent multicentre study in Lancet Oncology demonstrates that a multimodal deep learning model can predict Oncotype DX recurrence scores directly from H&E histopathology with high accuracy (AUC ~0.90) and consistent external validation across diverse cohorts. • AUC 0.898 for RS ≥26 • r=0.73 vs genomic score • External AUC 0.86–0.90 • HR 2.6–2.9 for recurrence endpoints Overall, this work represents a significant step toward integrating digital pathology and AI into therapeutic decision-making in breast cancer. Prospective trials are required before clinical implementation. @dviramar2 @TheLancetOncol @OncoAlert 👉 thelancet.com/journals/lanon…

40 years ago, a young physician submitted a paper reporting on the alteration of a gene called HER2/neu to Science. He didn’t know that it was the beginning of one of the most remarkable scientific stories of the human kind, which would eventually impact the lives of COUNTLESS patients with cancer — first via mABs, then through ADCs, bsAbs and beyond. Unforgettable Keynote presentation by Dennis Slamon at #MBCC26.

Do you have an impactful research idea? One that could improve patient care or advance scientific excellence? Apply for the ESMO Leadership & Career Development Award, offering protected research time, leadership & communication training by 3 May 26 🔗ow.ly/F4NM50Yqc9w #Oncology #ESMOYOC @TeresaSAmaral  @E_de_Azambuja  @DrAngelaLamarca @Rodrosb

New Real-Life Evidence on Adjuvant CDK4/6 Inhibitors in Colombia - Alfredo Sebastián Golemba @PabloMando oncodaily.com/voices/alfredo… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX

📣 #ESMOBreast26: One week left to share your studies! The field of breast cancer research is advancing rapidly — and your work can help shape the next breakthroughs. ⏰ Deadline: 27 January 2026 🔗 ow.ly/3Wri50XX7f5 #esmomeetings

📣Nueva edicion del @myESMO Virtual Mentorship Programme. Actividad recomendada para jovenes oncologos de latinoamerica! Programa de 12 meses que ofrece la oportunidad de ser emparejados con mentor de ESMO, quien brindará una mentoría 1:1. 📆 deadline 15/2 esmo.org/career-development/…

💭Can you imagine that you had a tool that could predict the risk of developing brain mets in pts with HER2 MBC? 😮Stop dreaming, this is real 🎯New generation biomarkers 🌍 International colab, 215 pts Come by and discuss our poster at #SABCS25 on Dec 12th @OncoAlert

Joined @DrHBurstein contest during #ESMO25 @myESMO review: proposed algorithm for first- and second-line #EndocrineTherapy in ER-positive/HER2-negative metastatic #BreastCancer @OncoAlert

Link de inscripción al Ciclo 2025: docs.google.com/forms/d/e/1F…

HER eBC management is improving survival but more complex. Here is a proposed algorithm with new advances post @myESMO #ESMO25 What do you think? What would you change? @matteolambe @PTarantinoMD @E_de_Azambuja @stolaney1 @Rodrosb @ElisaAgostinett @ErikaHamilton9 @hoperugo

What an amazing group with such a great leader!!! Proud to be member of @myESMO Young Oncologist Committee!

Best poster for advanced breast cancer in @myESMO for a project of @SUMAargentina 🇦🇷brilliantly led by @fwaisberg1 and presented by @ggabuin Working together is success! #ESMO25

According to this, and thinking of sequencing treatment options: would you consider TDXd for patients with a previous everolimus-related ILD? @PTarantinoMD @PabloMando @matteolambe

🩺 Ready to level up your oncology career? Check out the Young Oncologists sessions at #ESMO25 ! @myESMO Mentorship, masterclasses, and more. 💪#ESMOYOC #Oncology

This time I will follow from home. There's an amazing #ESMO25 coming up @myESMO Don't miss the #YOC track. Sad not to meet with friends @matteolambe @Rodrosb @DrJonLim @DrLizConnolly @lateuwen @E_de_Azambuja @AndresC27622123 @DrRBarroso